Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.
Journal: British journal of cancer
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Czajka-Francuz P, Twelves C, Spicer J, et al. (2026). "Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.". British journal of cancer. https://doi.org/10.1038/s41416-026-03543-6